Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like HbA1c to Estimated Average Glucose (eAG) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the HbA1c to Estimated Average Glucose (eAG)?
The HbA1c to Estimated Average Glucose (eAG) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in endocrinology & metabolism practice. Translates an HbA1c percentage into an estimated Average Glucose (eAG) in mg/dL or mmol/L. This helps patients better understand their HbA1c results by comparing them to the daily glucose readings on their home monitors. Clinical scoring tools like HbA1c to Estimated Average Glucose (eAG) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Empowers patients with diabetes to relate their quarterly HbA1c lab result to the daily fingerstick or Continuous Glucose Monitor (CGM) values they are accustomed to seeing.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate HbA1c to Estimated Average Glucose (eAG):
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 125 | Excellent Control (<6%) | green |
| 125 – 154 | Good Control (6-7%) | yellow |
| 154 – 212 | Fair Control (7-9%) | orange |
| ≥ 212 | Poor Control (>9%) | red |
When to Exercise Caution
The relationship between HbA1c and average glucose can be altered by conditions affecting red blood cell lifespan, such as hemolytic anemia, recent blood transfusion, or end-stage renal disease.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478.
Related Endocrinology & Metabolism Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Endocrinology & Metabolism:
Wells' Criteria for DVT
Calculates the pre-test probability of Deep Vein Thrombosis.
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
qSOFA Score
Quick Sequential Organ Failure Assessment for sepsis risk.
Centor Score
Estimates probability of streptococcal pharyngitis.
CURB-65 Score for Pneumonia
Estimates mortality of community-acquired pneumonia to help determine inpatient vs. outpatient treatment.
TIMI Risk Score for UA/NSTEMI
Estimates 14-day mortality, new MI, or urgent revascularization risk in UA/NSTEMI.